#Europace tweet pool ! PLEASE RETWEET 📱 ⚡️Is anxiety or depression common among Brugada syndrome patients? New data from the Danish national registry 🇩🇰 after giving your answer see the article below👇

Happy to announce that our study on disease manifestation and development of depression/anxiety in pts with #BrugadaSyndrome is out now in #Europace https://t.co/R3apkythkV @JacobTfelt @weekepe

Of great concern a newly published study by dr. @CamJespersen found that one in 3 patients with Brugada syndrome (BrS) were treated with a nonrecommended BrS drug after BrS diagnosis, and a BrS diagnosis did not change prescription patterns‼️💊

📢 Patients with BrS are recommended to avoid drugs that increases their risk of arrhythmic events. But what does the follow up really show?? Don't miss this GREAT work by @CamJespersen 👌 So happy to be a part of this! @weekepe @JacobTfelt @bowinkel75 https://t.co/lYmJjttO7I

Must read: new 2022 ventricular #arrhythmias and #SuddenCardiacDeath guidelines https://t.co/iaHhY0YQrj #ESCGuidelines #ESCCongress #cardiotwitter #medtwitter

In this nationwide study, torsades de pointes risk drug use increased in the time leading up to OHCA and was associated with reduced likelihood of presenting with a shockable rhythm and ROSC in an all-comer OHCA setting. 🔗 https://t.co/WeoZBdPXkQ #ResusTwitter

📢Excited to share our case has just been published in @JACCJournals! This report underlines how the “Sprint” exercise stress test may provoke arrhythmias better than the standard "Bruce" in #CPVT! @bowinkel75 @JacobTfelt @nkstampe @CamJespersen @JGrapsa https://t.co/RKJIOwdpTy

Is the severity of the cLQTS disease manifestation associated with detachment from the workforce after a cLQTS diagnosis? 🧐 find out in the newly published study by dr. @CamJespersen et al.🫀#RigsHeart

In this @Open_HeartBMJ sdy C Jespersen et al found that more than 90% of patients with cLQTS remained attached to the 👷👩‍💻👨‍💼 workforce 1️⃣ year after diagnosis, which was similar to a matched ↔️ background pop https://t.co/nDkufu9UC5 #cardiotwitter #Cardiology

In two minutes @CopCard, we present the sdy by @kr_johanna et al. about β-blocker adherence among patients with congenital Long QT Syndrome 1) 38% >= 1⃣ treatment break 2) ICD, psyc disease, β-blocker side effects⬆️discontinuation 🔗 https://t.co/EG4Cu9TLMj 📽️ @Pallisgaard_MD

In this @ESC_Journals quality of care sdy @kr_johanna et al found reduced β-blocker 💊 adherence was in ptts w congenital LQTS ➡️ ➡️ Psychiatric disease, side-effects, and ICD reduced adherence 🔗 https://t.co/tLGhrwHlk5 #CardioTwitter #Cardiology

Camilla Jespersen presenting "Use of non-recommended drugs in Brugada Syndrome: a Danish nationwide cohort study" 👏👏 #EHRA2022 #EHRA2022TogetherAgain #EHRA_ESC @JacobTfelt @ArthurWilde5